advertisement
11.4 Prostaglandins (15)
Showing records 1 to 15
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins13787 Melanin in the trabecular meshwork is associated with age, POAG but not latanoprost treatment. A masked morphometric study
Cracknell KP; Grierson I; Hogg P; Majekodunmi AA; Watson P; Marmion V
Experimental Eye Research 2006; 82: 986-993
13587 Recurrence of bilateral herpes simplex virus keratitis following bimatoprost use
Kothari MT; Mehta BK; Asher NS; Kothari KJ
Indian Journal of Ophthalmology 2006; 54: 47-48
13581 A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients
Martinez A; Sanchez M
Current Medical Research and Opinion 2006; 22: 67-73
13888 A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution
Denis P; Andrew R; Wells D; Friren B
European Journal of Ophthalmology 2006; 16: 407-415
13668 Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism
Hinz B; Rosch S; Ramer R; Tamm ER; Brune K
FASEB Journal 2005; 19: 1929-1931
13890 Latanoprost nonresponders with open-angle glaucoma in the Japanese population
Ikeda Y; Mori K; Ishibashi T; Naruse S; Nakajima N; Kinoshita S
Japanese Journal of Ophthalmology 2006; 50: 153-157
13891 Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes
Latanoprost-Induced Iris Pigmentation Study Group
Japanese Journal of Ophthalmology 2006; 50: 96-99
13685 The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma
Oh JY; Park KH
Korean Journal of Ophthalmology 2005; 19: 297-301
13650 Bimatoprost: A pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension
Plosker GL; Keam SJ
PharmacoEconomics 2006; 24: 297-314
13892 An evaluation of the rate of nonresponders to latanoprost therapy
Rossetti L; Gandolfi S; Traverso C; Montanari P; Uva M; Manni G; Carassa R; Mastropasqua L; Quaranta L; Marchini G
Journal of Glaucoma 2006; 15: 238-243
13889 Sustained effect of travoprost on diurnal and nocturnal intraocular pressure
Sit AJ; Weinreb RN; Crowston JG; Kripke DF; Liu JH
American Journal of Ophthalmology 2006; 141: 1131-1133
13718 Decreased high-density lipoprotein serum levels associated with topical bimatoprost therapy
Steinhauser SL
Optometry 2006; 77: 177-179
13675 The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery
Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 34-40
13893 The comparison of eyelash lengthening effect of latanoprost therapy in adults and children
Elgin U; Batman A; Berker N; Ilhan B
European Journal of Ophthalmology 2006; 16: 247-250
13725 Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes
Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
Veterinary Ophthalmology 2006; 9: 39-43
